(function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){ (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o), m=s.getElementsByTagName(o)[0];a.async=1;a.data-privacy-src=g;m.parentNode.insertBefore(a,m) })(window,document,'script','//www.google-analytics.com/analytics.js','ga'); ga('create', 'UA-1666707-3', 'auto'); ga('send', 'pageview');


About Zdravko Mauko

This author has not yet filled in any details.
So far Zdravko Mauko has created 59 blog entries.

Update about ANVISA´s role in pharmaceutical patent applications

In August 2017, the Brazilian Health Surveillance Agency (ANVISA) published Resolution No. 168/2017, which establishes the administrative procedures related to ANVISA´s “prior consent” for the granting of pharmaceutical patent applications,

By |2020-04-01T12:48:04+01:00March 12th, 2018|Regulatory Affairs|0 Comments

European “One-Stop-Shop” for Regulatory and Market Access Support

FarmavitaR+ is not only platform for on-line hiring of consultants, experts and freelances. We are also "one-stop-shop" for complex international projects.  To manufacturers of pharmaceuticals, biopharmaceutucals and medical devices, we offer

By |2020-04-01T12:48:05+01:00August 30th, 2016|FarmavitaR+ News|0 Comments
Go to Top